oncaspar
servier laboratories nz ltd - pegaspargase 3750 u (4050u including overage) - powder for injection - 3750 u/5ml - active: pegaspargase 3750 u (4050u including overage) excipient: dibasic sodium phosphate hydrochloric acid monobasic sodium phosphate sodium chloride sodium hydroxide sucrose - oncaspar is indicated as a component of antineoplastic combination therapy in patients with acute lymphoblastic leukaemia (all).
coversyl
servier laboratories nz ltd - perindopril erbumine 2mg - tablet - 2 mg - active: perindopril erbumine 2mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose silica, hydrophobic colloidal - coversyl is indicated for: · the treatment of hypertension;
coversyl
servier laboratories nz ltd - perindopril erbumine 4mg - tablet - 4 mg - active: perindopril erbumine 4mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose silica, hydrophobic colloidal - coversyl is indicated for: · the treatment of hypertension;
coversyl
servier laboratories nz ltd - perindopril erbumine 8mg - tablet - 8 mg - active: perindopril erbumine 8mg excipient: copper lactose monohydrate magnesium stearate microcrystalline cellulose silica, hydrophobic colloidal - coversyl is indicated for: · the treatment of hypertension;
coversyl
servier laboratories nz ltd - perindopril erbumine 2mg - tablet - 2 mg - active: perindopril erbumine 2mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose - coversyl is indicated for: · the treatment of hypertension.
coversyl
servier laboratories nz ltd - perindopril erbumine 4mg - tablet - 4 mg - active: perindopril erbumine 4mg excipient: colloidal silicon dioxide chlorophyllin aluminium lake (e14ii) lactose monohydrate magnesium stearate microcrystalline cellulose - coversyl is indicated for: · the treatment of hypertension.
coversyl
servier laboratories nz ltd - perindopril erbumine 8mg - tablet - 8 mg - active: perindopril erbumine 8mg excipient: colloidal silicon dioxide chlorophyllin aluminium lake (e14ii) lactose monohydrate magnesium stearate microcrystalline cellulose - coversyl is indicated for: · the treatment of hypertension.
onivyde
servier laboratories nz ltd - irinotecan hydrochloride trihydrate 5 mg/ml (equiv 4.3 mg/ml irinotecan (anhydrous free base)); - concentrate for infusion - 43 mg/10ml - active: irinotecan hydrochloride trihydrate 5 mg/ml (equiv 4.3 mg/ml irinotecan (anhydrous free base)) excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine cholesterol hepes n-(carbonyl-methoxypolyethylene glycol 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine sodium chloride sucrosofate water for injection - treatment of metastatic adenocarcinoma of the pancreas in combination with 5-fluorouracil and folinic acid (leucovorin) in adult patients who have been previously treated with gemcitabine
protos
servier laboratories nz ltd - strontium ranelate 2632mg - granules for oral suspension - 2 g - active: strontium ranelate 2632mg excipient: aspartame maltodextrin mannitol - treatment of severe (established) osteoporosis in postmenopausal women at high risk of fracture to reduce the risk of fracture.
locabiotal 125 microgram nasal spray solution
servier laboratories (ireland) ltd - fusafungine - nasal spray solution - 125 microgram